Browse AcZon literature by clicking the links below:

 

A new approach for the treatment of CLL using chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticles  

 

A non-canonical adenosinergic pathway led by CD38 in human melanoma cells induces suppression of T cell proliferation

 

Assessment of multiple dye doped core-shell silica nanoparticles uptake in U937 cell line

 

Bioconjugated fluorescent silica nanoparticles for immunofluorescence assays

 

Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice

 

CD56brightCD16- NK Cells Produce Adenosine through a CD38-Mediated Pathway and Act as Regulatory Cells Inhibiting Autologous CD4+ T Cell Proliferation

 

Circulating tumor cells in early breast cancer: A connection with vascular invasion

 

Fluorescent Nanoparticles as tool for next generation ADCs: site specific antibody conjugation strategies for highly pure targeting systems and accurate detection of drug delivery

 

Fluorescent nanoparticles-based new technology: preliminary studies for future applications as diagnostic tool and drug carrier  

 

Improved flow cytometry analysis of antibody bioconjugated nanoparticles (NPs) by primary amines quantification on NPs surface  

 

Intracytoplasmic staining procedure using new fluorescent stable probes based on nanoparticles technology (Best Poster Award ESCCA 2018)

 

Multiple dye doped core-shell silica nanoparticles

 

Multiple Dye Doped Core-Shell Silica Nanoparticles: Outstanding Stability and Signal Intensity Exploiting FRET Phenomenon for Biomedical Applications

 

Synthetic optimization of core-shell silica nanoparticles with tunable fluorescent characteristic: a novel probe for flow cytometry

 

Trehalose preserves the integrity of lyophilized phycoerythrin-antihuman CD8 antibody conjugates and enhances their thermal stability in flow cytometric assays

 

Unconventional, adenosine-producing suppressor T cells induced by dendritic cells exposed to BPZE1 pertussis vaccine.